Immunic Therapeutics - IMUX Company Short-Term Debt

Graphic logo of Immunic, Inc. (IMUX)

How does the risk of failed sclerosis drug trials impact the asset value of Immunic, Inc. (IMUX)? Short-term borrowed capital dynamics reflect the current trend, with the indicator settling at 0.00. Stability is maintained by competing with market behemoths despite a shortage of funds, while the efficiency of preclinical stages is enhanced through the implementation of AI and automated bioscreening.

IMUX (immunic-therapeutics.com) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Immunic Therapeutics - analytical breakdowns and key metrics (IMUX)

- price and consensus price forecast:
Price Chart Immunic Inc|IMUX - Fair Value Consensus
- market capitalization data:
Market Value Immunic Therapeutics|IMUX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Immunic|IMUX - Book Capitalization|Market Cap to Net Assets Ratio immunic-therapeutics.com|IMUX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Immunic, Inc.|IMUX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Immunic Inc|IMUX - Company Total Debt|Debt to Book Capitalization Ratio Immunic Therapeutics|IMUX - Company Long-Term Liabilities|Company Current Liabilities Immunic
Fundamental company valuation:immunic-therapeutics.com - IMUX
Product sample of Immunic Inc

To minimize long-term portfolio risks, liquidity control via the monitoring of short-term liabilities—measuring the volume of loans maturing within one year—is critically important. For Immunic, Inc. (IMUX), this metric reflects financial resilience against logistical disruptions and complexities in overseas drug registration, where rising debt signals a search for resources to overcome geopolitical barriers in component imports.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Company Short-Term Debts UPB (Upstream Bio Corp)|ZBIO: Short-Term Debt Volume|IMNM (Immunome, Inc.) - Company Short-Term Debt|GOSS (gossamerbio.com) - Company Current Liabilities|Company Short-Term Debt KALV|Company Current Liabilities Septerna, Inc. (SEPN)|Company Current Liabilities PVLA|Company Short-Term Debts SVRA (Savara Pharma)|RIGL - Company Short-Term Debt|Company Short-Term Indebtedness anaptysbio.com ANAB|Company Short-Term Debts ATXS (Astria Therapeutics, Inc.)|ENGN - Short-Term Debt Volume|RAPT (RAPT Therapeutics) - Company Short-Term Debts|Company Current Liabilities Aerovate Therapeutics|ACRS - Company Current Liabilities|Company Short-Term Loans and Borrowings kyvernatx.com|TLSA (Tiziana Life Sciences Ltd) - Company Short-Term Debts|Short-Term Debt Volume CABA (Cabaletta Bio Inc.)|VTYX - Company Short-Term Debt|Company Short-Term Indebtedness Theratechnologies, Inc THTX|AVTX: Company Short-Term Debts|eledon.com (ELDN) - Company Current Liabilities|Agenus Inc. - Company Current Liabilities|Climb Bio Inc. (CLYM) - Short-Term Debt Volume|ZURA: Company Short-Term Debts|Short-Term Debt Volume ATYR|Company Short-Term Debt ADAG (Adagene)|Company Current Liabilities ikenaoncology.com IMA|Company Current Liabilities STTK (Shattuck Labs)|EQ - Company Short-Term Debts|Connect Pharma (CNTB) - Company Current Liabilities|ATRA: Company Short-Term Indebtedness|Company Short-Term Debt inflarx.de (IFRX)|x4pharma.com (XFOR) - Current Liabilities|ACET - Company Short-Term Debts|Company Short-Term Loans and Borrowings Celularity Corp|Company Short-Term Debts INMB|Company Short-Term Debts BRNS (Barinthus Biotherapeutics Corp)|Company Short-Term Debt Kezar Life Sciences|sabbiotherapeutics.com - Company Short-Term Loans and Borrowings|AKTX: Company Short-Term Debt|ENLV - Company Current Liabilities|QTTB: Company Short-Term Debts|Company Short-Term Debts GeoVax Corp|EDSA - Company Current Liabilities|Company Short-Term Loans and Borrowings ibioinc.com|CARM (Carisma Therapeutics) - Company Short-Term Debts|Short-Term Debt Volume XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. - Company Short-Term Debt|HCW Biologics, Inc. - Company Current Liabilities|APVO: Company Short-Term Debt|aimimmuno.com (AIM) - Company Current Liabilities|ADTX: Company Current Liabilities|GRI (GRI Bio Inc) - Company Short-Term Debts|Company Short-Term Debt XORTX (XRTX)|Company Short-Term Indebtedness Vyome Therapeutics|Revelation Biosciences - Company Short-Term Debts|Short-Term Debt indaptusrx.com (INDP)|Company Short-Term Debts SCNI|CalciMedica Inc - Short-Term Debt Volume|AFMD: Company Short-Term Debt|ALLK: Company Current Liabilities|HOOK (hookipapharma.com) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|ITOS (iTeos Therapeutics, Inc.) - Company Current Liabilities|Company Short-Term Debts OCEA|Company Short-Term Debt TC BioPharm (Holdings) PLC TCBP|Company Short-Term Indebtedness Third Harmonic Bio Inc (THRD)